Inventor · disambiguated record
Michael Scherz
Also filed as: SCHERZ MICHAEL · SCHERZ MICHAEL W · SCHERZ MICHAEL WIARD
24 granted patents·10 pending applications·336 citations·filing 1980–2021
96Inventor score
Files withACTELION PHARMACEUTICALS LTD12PROCTER & GAMBLE6BINKERT CHRISTOPH4Metys Pharmaceuticals AG4AISSAOUI HAMED2
Top patents by PatentIndex Score
34 records- 0195USRE43833EThiazolidin-4-one derivativesBINKERT CHRISTOPH·Filed 2011·Granted Nov 27, 2012·21 cites·24 claims
- 0295US8273779B2Thiazolidin 4-one derivativesBINKERT CHRISTOPH·Filed 2009·Granted Sep 25, 2012·26 cites·19 claims
- 0395US7875726B2Thiazolidin-4-one derivativesACTELION PHARMACEUTICALS LTD·Filed 2008·Granted Jan 25, 2011·24 cites·7 claims
- 0494US8524752B2Thiazolidin-4-one derivativesBINKERT CHRISTOPH·Filed 2012·Granted Sep 3, 2013·22 cites·19 claims
- 0594US7626037B2Thiazolidin-4-one derivativesACTELION PHARMACEUTICALS LTD·Filed 2008·Granted Dec 1, 2009·24 cites·24 claims
- 0693USRE45174EThiazolidin-4-one derivativesACTELION PHARMACEUTICALS LTD·Filed 2013·Granted Sep 30, 2014·14 cites·8 claims
- 0792US9000018B2Thiazolidin-4-one-derivativesACTELION PHARMACEUTICALS LTD·Filed 2013·Granted Apr 7, 2015·13 cites·21 claims
- 0892US7435828B2Thiazolidin-4-one derivativesACTELION PHARMACEUTICALS LTD·Filed 2004·Granted Oct 14, 2008·33 cites·27 claims
- 0990USRE43728EThiazolidin-4-one derivativesBINKERT CHRISTOPH·Filed 2004·Granted Oct 9, 2012·25 cites·27 claims
- 1090US7750040B2Thiophene derivativesACTELION PHARMACEUTICALS LTD·Filed 2005·Granted Jul 6, 2010·17 cites·16 claims
- 1189US8785484B2Dosing regimen for a selective S1P1 receptor agonistBROSSARD PATRICK·Filed 2009·Granted Jul 22, 2014·19 cites·10 claims
- 1280US10251867B2Dosing regimen for a selective S1P1 receptor agonistACTELION PHARMACEUTICALS LTD·Filed 2015·Granted Apr 9, 2019·2 cites·7 claims
- 1375US5684002ADihydorbenzofuran and related compounds useful as anti-inflammatory agentsPROCTER & GAMBLE·Filed 1995·Granted Nov 4, 1997·19 cites·17 claims
- 1473US5510361ADi-tert-butylphenol compounds with heterocyclic moiety, useful as anti-inflammatory agentsPROCTER & GAMBLE·Filed 1994·Granted Apr 23, 1996·26 cites·14 claims
- 1573US2021401811A1Dosing regimen for a selective s1p1 receptor agonistACETLION PHARMACEUTICALS LTD·Filed 2021·Application pending·0 cites
- 1671US10660880B2Dosing regimen for a selective S1P1 agonistACTELION PHARMACEUTICALS LTD·Filed 2014·Granted May 26, 2020·0 cites·4 claims
- 1766US6815451B21,2,3,4-Tetrahydroisoquinolines derivatives as urotensin II receptor antagonistsACTELION PHARMACEUTICALS LTD·Filed 2002·Granted Nov 9, 2004·2 cites·18 claims
- 1864US7750161B2Pyridine derivativesBUR DANIEL·Filed 2004·Granted Jul 6, 2010·2 cites·12 claims
- 1964US7375227B2Quinoline derivativesACTELION PHARMACEUTICALS LTD·Filed 2002·Granted May 20, 2008·2 cites·23 claims
- 2062US2014303217A1Dosing regimen for a selective s1p1 receptor agonistACTELION PHARMACEUTICALS LTD·Filed 2014·Application pending·0 cites
- 2157US5684041ADihydrobenzofuran and related compounds useful as anti-inflammatory agentsPROCTER & GAMBLE·Filed 1996·Granted Nov 4, 1997·13 cites·17 claims
- 2256US10738054B2Synergistic compositions comprising (R)-dimiracetam (1) and (S)-dimiracetam (2) in a non-racemic ratioMetys Pharmaceuticals AG·Filed 2018·Granted Aug 11, 2020·0 cites·23 claims
- 2354US2020331919A1Synergistic compositions comprising (R)-dimiracetam (1) and (S)-dimiracetam (2) in a non-racemic ratioMetys Pharmaceuticals AG·Filed 2020·Application pending·0 cites
- 2453US5672620ADihydrobenzofuran and related compounds useful as anti-inflammatory agentsPROCTER & GAMBLE·Filed 1996·Granted Sep 30, 1997·11 cites·20 claims
- 2553US5656661ADihydrobenzofuran and related compounds useful as anti-inflammatory agentsPROCTER & GAMBLE·Filed 1995·Granted Aug 12, 1997·9 cites·16 claims
- 2653US2004242564A11,2,3,4-tetrahydroisoquinolines derivativesFiled 2004·Application pending·0 cites
- 2751US5674891ADihydrobenzothiophene compounds useful as anti-inflammatory agentsPROCTER & GAMBLE·Filed 1995·Granted Oct 7, 1997·8 cites·17 claims
- 2846US2006211707A1Piperazine-alkyl-ureido derivativesAISSAOUI HAMED·Filed 2004·Application pending·0 cites
- 2946US2007010516A1Novel piperidine derivativesAISSAOUI HAMED·Filed 2004·Application pending·0 cites
- 3045US2006079552A11-[2-(4-benzyl-4-hydroxy-piperidin-1-yl)-ethyl]-3-(2-methyl-quinolin-4-yl)-urea saltVELKER JORG·Filed 2004·Application pending·0 cites
- 3145US2006094716A11-Pyridin-4-yl-urea derivativesACTELION PHARMACEUTICALS LTD·Filed 2003·Application pending·0 cites
- 3243US2022047548A1SYNERGISTIC COMPOSITIONS COMPRISING (R)-2-(2-OXOPYRROLIDIN-1-YL)BUTANAMIDE AND (S)-2-(2-e OXOPYRROLEDIN-1-YL)BUTANAMEDE IN A NON-RACEMIC RATIOMetys Pharmaceuticals AG·Filed 2019·Application pending·0 cites
- 3336US2022047587A1Synergistic compositions comprising r-2-(substituted-sulfonyl)-hexahydro-pyrrolo[1,2-a]pyrazin-6(2h)-ones and s-2-(substituted-sulfonyl)-hexahydro-pyrrolo[1,2-a]pyrazin-6(2h)-ones in a non-racemic ratioMetys Pharmaceuticals AG·Filed 2019·Application pending·0 cites
- 3434US4323364AMethod of and apparatus for examining substances and mixtures of substancesSCHERZ MICHAEL·Filed 1980·Granted Apr 6, 1982·4 cites·15 claims
Join the waitlist — get patent alerts
Get an alert when Michael Scherz files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →